033 ADMISSION HEART RATE PREDICTS MORTALITY FOLLOWING PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-ELEVATION MYOCARDIAL INFARCTION. (24th May 2013)

• Record Type: Journal Article
• Authors: Balasubramaniam, K; Noman, A; Das, R; Kunadian, V; Ivanauskiene, T; Zaman, A
• Is Part Of: Heart. Volume 99(2013)Supplement 2
• Page Start: A24
• Page End: A25
• Publication Date: 2013-05-24
• Subjects: Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/heartjnl-2013-304019.33
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : Background: The prognostic value of admission heart rate (HR) on long-term mortality in ST-elevation myocardial infarction (STEMI) remains uncertain in the era of primary percutaneous coronary intervention (PPCI). Methods: Retrospective analysis of prospectively collected data of 2571 consecutive STEMI patients undergoing PPCI at a regional tertiary centre. Only patients in sinus rhythm on admission (n=2310) were included in this study, which aimed to assess the predictive value of admission HR on long-term mortality following PPCI and the influence of β-blockers on post-discharge survival. Results: Patients were classified according to admission heart rate: either low (≤70 beat per minute (bpm), n=1015) or high HR group (>70 bpm, n=1295). At a median follow-up of 559 days, all-cause mortality was 7.0% in the low HR group compared to 12.7% in the high HR group. In the Cox proportional hazard model corrected for several confounders, the adjusted HR for all-cause mortality in the high HR group was 1.59 (95% CI 1.15 to 2.20; p=0.005). Furthermore, every 10 bpm increase in admission heart rate was associated with 17% increase in all-cause mortality. Pharmacological intervention with β-blockers on discharge was associated with a reduction in post-discharge mortality only in the high HR group (adjusted HR, 0.49; 95% CI 0.31 to 0.77; p=0.002) versus 0.74 (95% CI 0.37 to 1.49; p=0.40) in the low HR group. Conclusions: Elevated admission heart rate in PPCI-treated STEMI patients is associated with long-term all-cause mortality. β-Blocker therapy improved post-discharge survival only in patients with elevated admission heart rate.Figure 1 Figure 2